OREANDA-NEWS. November 14, 2007. Orisil-Pharm Company , a pharmaceutical subsidiary of the Orisil , Ltd., has started production of a new medication “Atoxil” at their Kalush facility in Ukraine. This medication is used for absorption of toxins in cases of food poisoning and other related conditions. To prepare for the launch of this product, Orisil-Pharm Company undertook all necessary steps including preparation of sterile environments, installation of specialized equipment, obtaining government licenses and approvals.

The result of the program “Patient Care” was modernization of packaging which provides greater versatility in the available dosage types.

Orisil-Pharm is currently studying the potential of bringing “Atoxil” to a broader market.
Orisil-Pharm team would like to thank all the partners who participated in this endeavor and congratulates them with this achievement.